Cargando…

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus

SIV infection in macaques is a relevant animal model for HIV pathogenesis and vaccine study in humans. To design a safe and effective vaccine against HIV, we evaluated the suitability of naturally-occurring avirulent Newcastle disease virus (NDV) strains and several modified versions of NDV as vecto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manoharan, Vinoth K., Khattar, Sunil K., LaBranche, Celia C., Montefiori, David C., Samal, Siba K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997738/ https://www.ncbi.nlm.nih.gov/pubmed/29895833 http://dx.doi.org/10.1038/s41598-018-27433-x

Ejemplares similares

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques
por: Pahar, Bapi, et al.
Publicado: (2016)

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
por: Chamcha, Venkateswarlu, et al.
Publicado: (2016)

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
por: Shirvani, Edris, et al.
Publicado: (2020)

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
por: Abozeid, Hassanein H., et al.
Publicado: (2019)

Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques
por: Pahar, Bapi, et al.
Publicado: (2022)

Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1
por: Khattar, Sunil K., et al.
Publicado: (2010)

Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques
por: Gambhira, Ratish, et al.
Publicado: (2014)

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
por: Kim, Shin-Hee, et al.
Publicado: (2014)

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
por: Yoshida, Asuka, et al.
Publicado: (2019)

Role of fusion protein cleavage site in the virulence of Newcastle disease virus
por: Panda, Aruna, et al.
Publicado: (2004)

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
por: Bollimpelli, Venkata S., et al.
Publicado: (2023)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2017)

Recovery of Recombinant Avian Paramyxovirus Type-3 Strain Wisconsin by Reverse Genetics and Its Evaluation as a Vaccine Vector for Chickens
por: Elbehairy, Mohamed A., et al.
Publicado: (2021)

Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
por: Vaidya, Naveen K., et al.
Publicado: (2016)

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2023)

Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses
por: Cho, Yeonwoo, et al.
Publicado: (2018)

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
por: DiNapoli, Joshua M., et al.
Publicado: (2010)

Innate Immunity in Simian Immunodeficiency Virus Infection
por: Reeves, Roger Keith, et al.
Publicado: (2014)

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge
por: Mattapallil, Joseph J., et al.
Publicado: (2006)

Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire
por: Schaefer, Amanda, et al.
Publicado: (2005)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
por: Mohamed, Mahmoud HA, et al.
Publicado: (2011)

Quantification of Viral RNA and DNA Positive Cells in Tissues From Simian Immunodeficiency Virus/Simian Human Immunodeficiency Virus Infected Controller and Progressor Rhesus Macaques
por: Pahar, Bapi, et al.
Publicado: (2019)

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis
por: Paldurai, Anandan, et al.
Publicado: (2014)

Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico
por: Xiao, Sa, et al.
Publicado: (2013)

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2017)

Central African Hunters Exposed to Simian Immunodeficiency Virus
por: Kalish, Marcia L., et al.
Publicado: (2005)

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
por: Kim, Shin-Hee, et al.
Publicado: (2013)

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus
Publicado: (1995)

Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV
por: Wadford, Debra A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9k7mm20ak17umottdririd3pq2